Pharmacovigilance analysis of orlistat adverse events based on the FDA adverse event reporting system (FAERS) database

Abstract

Most of the adverse events found in this study are consistent with the results described in the drug label. At the same time, we also found some new adverse events, which require more prospective studies to verify and elucidate their relationship with orlistat.